| Clinical standards for the dosing and management of TB drugs JWC Alffenaar, SL Stocker, LD Forsman, A Garcia-Prats, SK Heysell, ... The International Journal of Tuberculosis and Lung Disease 26 (6), 483-499, 2022 | 51 | 2022 |
| Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis K Rustage, J Lobe, SE Hayward, KL Kristensen, I Margineanu, Y Stienstra, ... The Lancet Infectious Diseases 21 (12), 1701-1712, 2021 | 43 | 2021 |
| Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs J Kuhlin, MGG Sturkenboom, S Ghimire, I Margineanu, ... Clinical Mass Spectrometry 14, 34-45, 2019 | 22 | 2019 |
| Practices of therapeutic drug monitoring in tuberculosis: an international survey I Margineanu, O Akkerman, D Cattaneo, D Goletti, DJE Marriott, ... European Respiratory Journal 59 (4), 2022 | 19 | 2022 |
| eHealth in TB clinical management I Margineanu, C Louka, O Akkerman, Y Stienstra, JW Alffenaar The International Journal of Tuberculosis and Lung Disease 26 (12), 1151-1161, 2022 | 11 | 2022 |
| Patients and medical staff attitudes toward the future inclusion of ehealth in tuberculosis management: Perspectives from six countries evaluated using a qualitative framework I Margineanu, C Louka, M Vincenti-Gonzalez, AMI Saktiawati, J Schierle, ... JMIR mHealth and uHealth 8 (11), e18156, 2020 | 9 | 2020 |
| Clinical standards for the management of adverse effects during treatment for TB KP Singh, ACC Carvalho, R Centis, GB Migliori, SG Mpagama, ... The International Journal of Tuberculosis and Lung Disease 27 (7), 506-519, 2023 | 8 | 2023 |
| Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020 I Margineanu, K Rustage, T Noori, D Zenner, C Greenaway, M Pareek, ... Eurosurveillance 27 (12), 2002070, 2022 | 5 | 2022 |
| ESGITM and ESGMYC study groups. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: A systematic review and meta-analysis K Rustage, J Lobe, SE Hayward, KL Kristensen, I Margineanu, Y Stienstra, ... Lancet Infect. Dis 21, 1701-1712, 2021 | 4 | 2021 |
| Asthma-like symptoms in a patient with rheumatoid arthritis and Adalimumab treatment. I Mărgineanu, R Crişan, T Mihăescu Pneumologia (Bucharest, Romania) 64 (4), 28-30, 2015 | 4 | 2015 |
| TB and COVID-19 in migrants–the need to focus on both conditions I Margineanu, Z Mor, D Garcia, C Gilpin, S Dhawan, N Ritz, D Zenner The International Journal of Tuberculosis and Lung Disease 25 (5), 333-335, 2021 | 3 | 2021 |
| Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs”[Clin. Mass Spectrom. 14 (Part A)(2019) 34–45] J Kuhlin, MGG Sturkenboom, S Ghimire, I Margineanu, ... Journal of mass spectrometry and advances in the clinical lab 25, 72, 2022 | 1 | 2022 |
| Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug‐susceptible and drug resistant patients: A patient‐reported outcome measures study I Margineanu, T Butnaru, M Lam, D Baiceanu, R Dragomir, AS Arbore, ... Tropical Medicine & International Health, 2024 | | 2024 |
| TB therapeutic drug monitoring–analysis of opportunities in Romania and Ukraine I Margineanu, T Butnaru, F Gafar, D Baiceanu, R Dragomir, I Semianiv, ... The International Journal of Tuberculosis and Lung Disease 27 (11), 816-821, 2023 | | 2023 |
| Prospects for the use of artificial intelligence to predict the spread of tuberculosis infection in the WHO European Region L Todoriko, O Andriiets, Y Vyklyuk, I Semyaniv, I Margineanu, E Lesnik, ... Tuberculosis, Lung Diseases, HIV Infection 53 (2), 86-92, 2023 | | 2023 |
| Personalised approaches to improve tuberculosis care: Cutting tuberculosis’ many coats according to specific cloths I Margineanu | | 2023 |
| Personalised approaches to improve tuberculosis care I Margineanu | | 1988 |
| Country-Specific Approaches to Latent Tuberculosis Screening Targeting Migrants in EU/EEA Countries I Margineanu, K Rustage, T Noori, D Zenner, C Greenaway, M Pareek, ... Personalised approaches to improve tuberculosis care 27 (12), 95, 1988 | | 1988 |
| Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020 L Spallanzani people (roughly 25% of the world population) 1, 3, 0 | | |
Radu Crisan DabijaUniversitatea de Medicina si Farmacie "Grigore T. Popa" Iasi在 umfiasi.ro 的电子邮件经过验证
Radu Crisan DabijaUniversitatea de Medicina si Farmacie "Grigore T. Popa" Iasi在 umfiasi.ro 的电子邮件经过验证